Dystrophic animal models have promoted understanding of DMD pathology, leading to the development of various candidate therapies aimed at restoring the expression of dystrophin protein or correcting physiological pathways involved in the pathogenesis [9,10]. Here, DMD is linked to Duchenne muscular dystrophy.